Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

This remains challenging owing to the lack of induction methods that imitate the natural programming process. Endogenous gene regulation of tissue-specific transcription factors is therefore desirable ...

Cover Credit: AAV-mediated CAS9 delivery to the hippocampus is drastically improved by opening the blood-brain barrier (BBB). Genome editing has an assured place in the future of therapies for ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...